Paper Details

  1. Home
  2. Paper Details

Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.

Author: AldenkampA P, ArendsJ, BootsmaH P R, DiepmanL, HulsmanJ, LambrechtsD, LeenenL, MajoieM, SchellekensA, de VochtJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Lamotrigine improved cognitive activation and mood in healthy volunteers, while valproate had the opposite effect.
Paper Details　
Original Abstract of the Article :
PURPOSE: This study aimed at investigating the cognitive and mood effects of lamotrigine (LTG) versus valproate (VPA) and placebo (PBO). METHODS: By studying the effects in healthy volunteers, it is possible to separate the genuine effects of LTG from the cognitive improvements, caused by better se...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1528-1157.2002.29201.x

データ提供：米国国立医学図書館（NLM）

Cognitive Effects of Lamotrigine Versus Valproate: A Desert of Mental Clarity

This study explores the fascinating world of cognitive function, investigating the effects of lamotrigine and valproate, two medications commonly used to treat epilepsy, on cognitive performance in healthy individuals. The researchers conducted a double-blind study to compare the cognitive and mood effects of lamotrigine, valproate, and a placebo. They found that lamotrigine, at a low dose, significantly improved cognitive activation and reduced drug-related cognitive complaints compared to valproate and the placebo. This research is like discovering a hidden oasis of mental clarity in the vast and often-challenging desert of cognitive function, offering insights into potential therapeutic benefits for certain medications.

Lamotrigine's Positive Cognitive Effects

The study found that lamotrigine, at a low dose, improved cognitive activation and reduced drug-related cognitive complaints compared to valproate and the placebo. This is like finding a clear spring in a desert, offering a refreshing source of mental clarity and focus. The study's findings suggest that lamotrigine could be a beneficial option for individuals who are concerned about the cognitive side effects of other medications.

Navigating Cognitive Function: A Desert of Complexities

Cognitive function is a complex process that can be affected by a variety of factors, including medications. This study provides valuable insights into the cognitive effects of lamotrigine and valproate, two medications commonly used to treat epilepsy. The researchers' findings highlight the importance of considering the cognitive impact of medications, particularly in individuals who rely on optimal cognitive function for everyday tasks.

Dr. Camel's Conclusion

This study offers valuable insights into the cognitive effects of lamotrigine and valproate, two medications commonly used to treat epilepsy. The researchers' findings suggest that lamotrigine, at a low dose, could be a beneficial option for individuals who are concerned about the cognitive side effects of other medications, offering a potential oasis of mental clarity in the vast and often-challenging desert of cognitive function.
Date :
  1. Date Completed 2002-04-12
  2. Date Revised 2019-08-13
Further Info :

Pubmed ID

11879382

DOI: Digital Object Identifier

10.1046/j.1528-1157.2002.29201.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.